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A robust increase in the functional expression of the neuronal KeCl cotransporter KCC2 during CNS
development is necessary for the emergence of hyperpolarizing ionotropic GABAergic transmission.
BDNF-TrkB signaling has been implicated in the developmental up-regulation of KCC2 and, in mature
animals, in fast activity-dependent down-regulation of KCC2 function following seizures and trauma. In
contrast to the decrease in KCC2 expression observed in the adult hippocampus following trauma, sei-
zures in the neonate trigger a TrkB-dependent up-regulation of neuronal Cl extrusion capacity asso-
ciated with enhanced surface expression of KCC2. Here, we show that this effect is transient, and
impaired in the hippocampus of Bdnf/ mice. Notably, however, a complete absence of BDNF does not
compromise the increase in KCC2 protein or K-Cl transport functionality during neuronal development.
Furthermore, we present data indicating that the functional up-regulation of KCC2 by neonatal seizures
is temporally limited by calpain activity.
This article is part of the Special Issue entitled ‘GABAergic Signaling in Health and Disease’.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Progressive up-regulation of the neuron-speciﬁc multifunc-
tional KeCl cotransporter KCC2 during rodent postnatal develop-
ment is required for the emergence of hyperpolarizing GABAA
receptor (GABAAR)-mediated responses in hippocampal and
neocortical principal neurons (Blaesse et al., 2009; Blaesse and
Schmidt, 2014; Kaila et al., 2014a; Rivera et al., 1999). This
straightforward dependence of the ontogeny of hyperpolarizing
inhibition on the developmental expression of KCC2 belies a much
more intricate mechanistic scenario where the expression of KCC2
protein is a necessary but not sufﬁcient condition for the above
functional outcome (Blaesse et al., 2009; Kahle et al., 2013). For
instance, work on the rodent auditory brainstem has demonstrated
that, despite similarly high expression levels of KCC2 protein in the
early postnatal period and during the ﬁrst month of life, the ca-
pacity to extrude Cl in neurons of the lateral superior olive
emerges gradually during the ﬁrst two weeks of life (Balakrishnanof Physiology I, Westf€alische
many.
se).
nstitute of Science, Bangalore
Ltd. This is an open access article uet al., 2003; Blaesse et al., 2006). Indeed, mounting evidence sug-
gests that KCC2 protein is functionally activated by phosphorylation
mechanisms targeting its C-terminal domain (Chamma et al., 2012;
Kahle et al., 2013; Kaila et al., 2014a; Medina et al., 2014). Obser-
vations of this kind, underscored by the fast membrane trafﬁcking
of KCC2 (Khirug et al., 2010; Lee et al., 2007), point to powerful
post-translational control of KCC2 functionality (Blaesse et al.,
2009; Kahle et al., 2013; Kaila et al., 2014a).
The development of postsynaptic GABAAR-mediated responses
is also strongly inﬂuenced by the NaeKe2Cl cotransporter NKCC1.
While NKCC1 has gained considerable attention in the context of
neonatal seizures (for review, see Briggs and Galanopoulou, 2011;
L€oscher et al., 2013; Nardou et al., 2013; Puskarjov et al., 2014a),
only a few studies have addressed the involvement of KCC2
(Galanopoulou, 2007, 2008; Khirug et al., 2010; Nardou et al., 2011).
We have recently shown that a single episode of neonatal seizures
in rats at postnatal day (P) 5e7 in vivo and epileptiform activity
in vitro both result in enhanced membrane insertion and fast
functional activation of KCC2 without altering KCC2 synthesis
(Khirug et al., 2010). The activity-dependent functional KCC2 up-
regulation was fully blocked by tetrodotoxin (TTX) and K252a
(Khirug et al., 2010), an efﬁcient inhibitor of the BDNF receptor
TrkB. Here we show that the rapid but transient seizure-induced
functional up-regulation of KCC2 is absent in neonatal Bdnf/nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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postnatal life (Di Lieto et al., 2012). Unexpectedly (cf. Aguado et al.,
2003; Ludwig et al., 2011b), no difference was detected in the
developmental up-regulation of either KCC2 total protein or func-
tionality between Bdnf/ and Bdnfþ/þ genotypes. Thus, the present
ﬁndings indicate that BDNF-TrkB signaling is required for short-
term, seizure-induced post-translational functional activation of
KCC2. BDNF itself does not appear to be a necessary factor for the
developmental up-regulation of KCC2 protein and neuronal Cl
extrusion, but, as previously demonstrated it may act as a powerful
modulator of KCC2 mRNA and protein expression in developing
neurons (cf. Aguado et al., 2003; Ludwig et al., 2011b).
2. Materials and methods
2.1. Induction and scoring of neonatal seizures in Bdnf/ and Bdnfþ/þ mice
Bdnfþ/mice (Ernfors et al., 1994) used for generation of homozygous Bdnf/
and Bdnfþ/þ pups were kindly provided by Dr. Eero Castren, Neuroscience Center,
University of Helsinki. The genetic background of the mice was C57BL/6. Experi-
ments were carried out with approval by the National Animal Ethics Committee of
Finland and the local Animal Ethics Committee of the University of Helsinki. All
efforts were made to minimize animal suffering, to reduce the number of animals
used, and to consider alternatives to in vivo techniques.
Seizures were induced in P6 Bdnf/ and Bdnfþ/þ pups with a single 10 ml
intraperitoneal injection of kainate (2 mg/kg; Tocris) dissolved in saline (0.9% NaCl).
Following injection, the pups were maintained for 90min in a chamber preheated to
a temperature of 33 ± 1 C. Continuous behavioral monitoring was performed
throughout this period via video recording and seizure severity was scored ofﬂine.
Due to vestibular deﬁcits, naïve Bdnf/ mice are characterized by difﬁculty
remaining upright and by ataxia (Ernfors et al., 1994; Jones et al., 1994). Obviously,
this precludes the use of loss of righting reﬂex or clonic movements for scoring of
behavioral seizures. Tonic hindlimb extension, a sign of severe behavioral seizures in
neonatal rodents (Velisek et al., 1995), was not observed in naïve Bdnf/ mice, and
was used to assess the severity of seizures in Bdnfþ/þ and Bdnf/ pups. To this end,
individual video recordings were reviewed in an experimenter-blind manner at
intervals of one minute. At every 60 s, the video was viewed for ten seconds and,
provided during this period hindlimb tonus was observed, a score of 1 was given;
otherwise the animal scored 0 for the period. A cumulative score was deduced for
each animal by the sum of scores given over 90 min after injection. The latency to
onset of tonic seizures was taken as the time to score two consecutive hindlimb
extensions.
2.2. Preparation of acute brain slices
Coronal 400 mm thick brain slices containing the dorsal hippocampus were
prepared 90 min after the injection of kainate or saline (Fig. 1A) as described pre-
viously (Khirug et al., 2010). Following decapitation, brains were quickly removed
and immersed into ice-cold physiological solution containing (in mM): 124 NaCl, 3
KCl, 2 CaCl2, 25 NaHCO3, 1.1 NaH2PO4, 2 MgSO4, and 10 D-glucose, equilibrated with
95% O2 and 5% CO2. Slices were cut using a Campden 7000smz vibrating microtome
(Campden Instruments). Before experiments were started, slices were allowed to
recover for 1 h at 35 ± 1 C.
2.3. Assessment of the efﬁcacy of neuronal Cl extrusion
To gain a quantitative estimate of the efﬁcacy of neuronal Cl extrusion, we used
our standard assay where a constant somatic Cl load (19 mM) is imposed on the
neuron via a whole-cell patch pipette (Khirug et al., 2005). The steepness of the
ensuing bumetanide-insensitive somatodendritic EGABA gradient (DEGABA), deter-
mined as the difference between the EGABA at the soma and at 50 mm away along the
apical dendrite, has been demonstrated to provide a quantitative estimate of the
efﬁcacy of KCC2-mediated Cl extrusion (Blaesse et al., 2006; Gauvain et al., 2011;
Jarolimek et al., 1999; Khirug et al., 2005, 2008, 2010; Li et al., 2007; Puskarjov
et al., 2012, 2014b). Whole-cell patch-clamp recordings were done in the presence
of 10 mM bumetanide (Tocris) to inhibit NKCC1, 0.5 mM TTX (Abcam) to block
voltage-gated Naþ channels, 10 mM CNQX (Abcam) to inhibit AMPA/kainate
signaling, and 1 mM CGP 55845 (Abcam) to block GABAB receptor-mediated
signaling. Part of the P6 slices were exposed to the calpain inhibitor MDL-28170
(30 mM; Tocris) (Puskarjov et al., 2012) throughout the post-recovery period and
used for electrophysiological recordings or biochemical analysis during the 4th hour
after recovery. After establishing whole-cell conﬁguration, each neuronwas allowed
to equilibrate with the pipette solution for at least 5e10 min. The pipette solution
consisted of (in mM): 18 KCl, 111 K-gluconate, 0.5 CaCl2, 2 NaOH, 10 glucose, 10
HEPES, 2 Mg-ATP, and 5 BAPTA, 0.1 Alexa Fluor 488; pH was adjusted to 7.3 with
KOH. Data obtained from cells with stable access resistance between 10 and 20 MU
and resting membrane potential below 55 mV were used for further analysis.
Membrane potential values were corrected for calculated liquid junction potentials(Barry, 1994). Somatic and dendritic EGABA values were consecutively determined
from the currentevoltage relations, obtained by sequentially clamping the mem-
brane potential for 200 ms at six different voltage levels with a 5 mV increment and
a 10 s step interval. DPNI-caged GABA (1 mM; Tocris) (Puskarjov et al., 2012; Trigo
et al., 2009, 2010) was dissolved in the physiological solution containing the
above drugs and delivered in the vicinity of the patched neuron at a ﬂow rate of
1e2 ml/min via an UltraMicroPump II (WPI) equipped with a syringe and a 100 mm
inner tip diameter quartz needle (WPI). To evoke local GABAAR-mediated currents at
the soma or at the apical dendrite, GABA was locally uncaged using a ~10 mm
diameter 10 ms long UV-ﬂash (372 nm) 50 ms after the start of each voltage step
(Khirug et al., 2005; Puskarjov et al., 2012). The 50 mm distance from the soma along
the apical dendrite was traced using a Radiance 2100 confocal microscope (Bio-Rad)
and Alexa Fluor 488 in the patch pipette (Khirug et al., 2008; Puskarjov et al., 2012).
An earlier study reported a gender-related difference in the reversal potentials of
GABAAR-mediated currents in CA1 pyramidal neurons of P4e7 rats that had un-
dergone multiple saline injections (Galanopoulou, 2008). However, presently, no
signiﬁcant difference in the Cl extrusion capacity of CA1 pyramidal neurons be-
tween P6 male and female Bdnfþ/þ mice was observed after a single injection of
saline (DEGABA in males: 3.03 ± 0.24 mV/50 mM; n ¼ 11 neurons; DEGABA in
females: 3.54 ± 0.32 mV/50 mM; n ¼ 13 neurons; p ¼ 0.232; ManneWhitney Rank
Sum Test). Thus, data from male and female mice were pooled in the present study.
2.4. Analysis of KCC2 surface expression
A protease approach (Ahmad et al., 2011; Khirug et al., 2010; Puskarjov et al.,
2012) was used to measure the surface expression of KCC2. In brief, 30 min after
recovery, slices were treated with cod trypsin (Zymetech), a cold-adapted protease
that retains its activity at low temperatures while trafﬁcking of membrane proteins
is prevented (Ahmad et al., 2011). Slices were incubated on ice for 60 min in the
presence of cod trypsin (2 U/ml). The cleavage reaction was stopped by adding the
trypsin inhibitor phenylmethylsulfonyl ﬂuoride (100 mM; 5 min on ice). After ho-
mogenization the samples were analyzed using immunoblotting.
2.5. Quantitative immunoblotting
Immunoblot analysis was performed on hippocampal slices and whole hippo-
campi as described previously (Puskarjov et al., 2012). A polyclonal rabbit-anti-
panKCC2 antibody (1:1000; Ludwig et al., 2003) was used for KCC2 and rabbit-
anti tubulin (1:20,000; Nordic BioSite, catalog #PRB-435P) for reference. For some
blots, afﬁnity-puriﬁed rabbit-anti-panKCC2 antibody was used to detect the cod
trypsin cleavage product of KCC2. The secondary antibody used was horseradish
peroxidase-conjugated donkey-anti-rabbit IgG (1:3000; GE Healthcare). Immuno-
reactivity was detected using an enhanced chemiluminescence detection kit (Pierce)
and a LAS-3000 documentation system (Fujiﬁlm). Quantiﬁcation was performed
using AIDA software (Raytest).
3. Results
3.1. Seizure-induced activation of KCC2 is impaired in the neonatal
Bdnf/ hippocampus
Consistent with previous work in P5-7 rats (Khirug et al., 2010),
an episode of neonatal seizures induced by kainate injection in P6
Bdnfþ/þmice resulted in a fast increase in the Cl extrusion capacity
of CA1 pyramidal neurons (Figs. 1BeF; mean DEGABA of neurons
recorded up to 90min after recovery from slicing:5.58± 0.38mV/
50 mm; n ¼ 18 neurons; p ¼ 0.002, when compared to saline-
injected controls: 3.44 ± 0.43 mV/50 mm; n ¼ 10 neurons). No
signiﬁcant sex-related difference (see Methods) in seizure-induced
up-regulation of Cl extrusion capacity was observed (respective
DEGABA values in males 5.18 ± 0.42 mV/50 mm, n ¼ 13, and
females 6.03 ± 1.05 mV/50 mm, n ¼ 5; p ¼ 0.186; one-tailed Stu-
dent's t-test). In contrast, the mean DEGABA value in neurons from
kainate-injected Bdnf/ animals was only 3.89 ± 0.37 mV/50 mm
(n¼ 13 neurons), which is signiﬁcantly lower than the DEGABA from
kainate-injected Bdnfþ/þ pups (p ¼ 0.007) and not different from
saline-injected Bdnfþ/þ animals (p ¼ 0.477; one-way ANOVA with
Holm-Sidak post hoc test). This level is identical to that observed in
the presence of furosemide (Khirug et al., 2010) indicating the
absence of KCC2 activity in neurons from kainate-injected Bdnf/
and saline-injected Bdnfþ/þ mice at P6.
Partial suppression of electrical kindling has been demonstrated
in adult Bdnfþ/and Bdnf/ mice (Barton and Shannon, 2005; He
Fig. 1. Activation of KCC2 after a single episode of kainate-induced neonatal seizures in the P6 hippocampus is impaired in the absence of BDNF. A, Schematic timeline of the
experimental protocol for P6 Bdnf/ and Bdnfþ/þ mice. BeF, Whole-cell patch-clamp recordings of uncaging-induced GABAAR-mediated currents (IGABA) and EGABA in CA1 pyra-
midal neurons under an imposed somatic Cl load demonstrated an increase in the somatodendritic EGABA gradient (DEGABA) after an episode of kainate-induced seizures in Bdnfþ/þ
but not in Bdnf/ mice (sal, saline; KA, kainate). BeD, Sample EGABA recordings during the ﬁrst 90 min after recovery from slicing. Uncaging ﬂash indicated by horizontal bars. E,
Scatter plot of DEGABA over time in CA1 pyramidal neurons in slices from kainate- or saline-treated Bdnfþ/þ and kainate-treated Bdnf/ animals. Linearly ﬁtted lines illustrate the
main trends in the respective data sets. F, The mean DEGABA value in kainate-injected Bdnfþ/þ mice was signiﬁcantly higher compared to both saline-injected Bdnfþ/þ and kainate-
injected Bdnf/ during the ﬁrst ~90 min, with progressive down-regulation of DEGABA ensuing thereafter. G, Surface expression of KCC2 was signiﬁcantly lower after the seizure
episode in hippocampal slices from Bdnf/ mice compared to slices from wildtype littermates. The surface/internal ratio (ratio of trypsin-cleaved KCC2 [~100 kDa; surface] to
uncleaved KCC2 [~140 kDa; internal]) measured in slices from Bdnf/ was normalized with respect to Bdnfþ/þ. No difference in total KCC2 protein was observed between kainate-
injected Bdnf/ and Bdnfþ/þ mice. *p < 0.05; **p < 0.01. Error bars denote SEM.
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lower doses of pilocarpine are needed to produce limbic seizures in
adult Bdnfþ/ mice (Barton and Shannon, 2005). Therefore we
investigated whether the absence of KCC2 activation in Bdnf/animals may be due to potentially suppressed seizure generation.
No signiﬁcant difference in severity of kainate-induced seizures
(see Methods) was observed between P6 Bdnf/ and Bdnfþ/þ ani-
mals (seizure severity score: 39.6 ± 5.2; n ¼ 10 Bdnf/ pups vs.
M. Puskarjov et al. / Neuropharmacology 88 (2015) 103e10910629.9 ± 5.7; n ¼ 14 Bdnfþ/þ pups; p ¼ 0.169; ManneWhitney Rank
Sum Test). The difference in the latency to onset of tonic seizures
was also not statistically signiﬁcant (Bdnf/: 18.2 ± 4.1 min; n¼ 10
pups vs. Bdnfþ/þ: 30.6 ± 6.6 min; n ¼ 14 pups; p ¼ 0.127;
ManneWhitney Rank Sum Test), supporting the earlier observation
by Barton and Shannon (2005) of no difference between BDNF-
deﬁcient and wildtype mice in seizure thresholds for tonic-clonic
seizures induced by electrical stimulation. The above results sug-
gests that under the present conditions, the difference in KCC2
activation between the two genotypes is unlikely to stem
from differences in the severity of the seizures experienced by the
Bdnf/ and Bdnfþ/þ animals.
The seizure-induced enhancement of neuronal Cl extrusion
capacity in neonatal rats is not associated with increased KCC2
total protein, but it is paralleled by a robust increase in the sur-
face expression of KCC2 that is sensitive to TTX and the kinase
inhibitor K252a (Khirug et al., 2010). Accordingly, KCC2 surface
expression (surface/internal ratio) was signiﬁcantly lower in sli-
ces from kainate-injected Bdnf/ pups than in kainate-injected
wildtype littermates, quantiﬁed immediately after slicing recov-
ery (Fig. 1G; 68.8 ± 8% of the level in kainate-injected Bdnfþ/þ
littermates; with n ¼ 6 slices from both genotypes; p ¼ 0.031;
Wilcoxon matched pairs test). As expected, no difference was
observed in the total protein level between kainate-injected
Bdnf/ and Bdnfþ/þ littermates (Fig. 1G; 98.3 ± 6.0% of Bdnfþ/þ;
n ¼ 4 slices from both genotypes; p ¼ 0.4; one-tailed Student's
paired t-test).
To investigate whether the seizure-induced functional up-
regulation of KCC2 is delayed in the absence of BDNF expres-
sion, we extended DEGABA measurements to time points later
than 90 min after recovery (Figs. 1A and E). No change in DEGABA
was observed during the entire experimental time window of
240 min in the kainate-injected Bdnf/ group (mean DEGABA at
90e180 min: 3.6 ± 0.35 mV/50 mm; n ¼ 10 neurons; at
180e240 min: 3.59 ± 0.26 mV/50 mm; n ¼ 5 neurons; p ¼ 0.803,
when comparing the mean DEGABA values recorded during 0e90,
90e180, and 180e240 min after recovery; one-way ANOVA). In
contrast, a progressive down-regulation of the initial negative
shift in DEGABA was observed in neurons from kainate-injected
Bdnfþ/þ mice, reaching statistical signiﬁcance during the 4th
hour (180e240 min) after recovery (Fig. 1E, F and 2A; mean
DEGABA at 90e180 min: 4.82 ± 0.47 mV/50 mm; n ¼ 13 neurons;
mean DEGABA at 180e240 min: 3.44 ± 0.30 mV/50 mm; n ¼ 6Fig. 2. Neonatal seizure-induced activation of KCC2 is temporally limited by calpain activity.
kainate-injected Bdnfþ/þ animals were no longer different from the respective level measure
incubated slices from kainate-injected Bdnfþ/þ animals were signiﬁcantly higher than those
group (see Fig. 1F). B, Down-regulation of KCC2 total protein observed at the 4th hour afte
Representative Western blot analysis and quantiﬁcation of KCC2 total protein after the seiz
240minutes ± MDL was normalized with respect to Bdnfþ/þ to the 0 min level in slices froneurons; p ¼ 0.018 for the mean DEGABA at 180e240 min vs. the
mean DEGABA values recorded during 0e90 min; and p ¼ 0.891 vs.
mean saline DEGABA values at 180e240 min: 3.33 ± 0.31 mV/
50 mm; n ¼ 7 neurons; one-way ANOVA with Holm-Sidak post
hoc test). Interestingly, during the 4th hour after recovery, we
observed also a signiﬁcant decrease in the total KCC2 protein
levels in slices from kainate-injected Bdnfþ/þ pups (Fig. 2B;
80.1 ± 5% at 240 min of the level measured immediately after
recovery [0 min in Fig. 1A] in slices from the same animal; n ¼ 10
slices for both groups; p ¼ 0.011; one-way repeated measures
ANOVA with Tukey's post hoc test). This effect is unlikely to be
attributable to putative progressive deterioration of brain tissue
due to damage caused by slicing as evidenced by the fact that,
under control conditions in hippocampal slices, the total and
functional KCC2 protein pools are stable for several hours
(Puskarjov et al., 2012).
Recent work (Chamma et al., 2013; Puskarjov et al., 2012; Zhou
et al., 2012) has shown that KCC2 is down-regulated by the Ca2þ-
activated protease calpain as a consequence of strongly enhanced
glutamatergic signaling. Kainate-induced seizure activity has been
reported to result in calpain activation in the CA1 stratum radiatum
of P7 rats 4 h after seizure onset (Bi et al., 1997). Thus, we tested
whether the delayed down-regulation of KCC2 following neonatal
seizures is sensitive to the calpain inhibitor MDL-28170 applied
immediately after recovery. In the absence of calpain activity,
signiﬁcantly higher DEGABA values were observed in slices from
kainate-injected Bdnfþ/þ animals during the 4th hour after recovery
(Fig. 2A; 5.18 ± 0.31 mV/50 mm; n ¼ 6 neurons; p ¼ 0.003, vs.
respective 180e240 min values without MDL-28170; one-way
ANOVA with Holm-Sidak post hoc test). Likewise, down-regulation
of KCC2 protein was fully blocked by MDL-28170 (Fig. 2B;
109 ± 6.4% of the level measured at 0 min; n ¼ 10 slices; p ¼ 0.965
and 0.006, respectively, vs. levels in slices from the same animal at
0 and 240 min after recovery; one-way repeated measures ANOVA
with Tukey's post hoc test). It has been previously demonstrated
that, under control conditions, blocking protein degradation,
including constitutive calpain activity, does not result in signiﬁcant
up-regulation of KCC2 protein in the present timescale of 4 h
(Puskarjov et al., 2012), suggesting that the effect obtained with
MDL-28170 is unlikely to be accounted by unmasking of KCC2 de
novo synthesis.A, During the 4th hour after recovery (240 min) DEGABA values of neurons in slices from
d from saline-injected controls. DEGABA values measured in MDL-28170 (MDL; 30 mM)-
measured during the 4th hour without MDL and remained at the level of the 0e90 min
r recovery in slices from kainate-injected Bdnfþ/þ animals is prevented by MDL-28170.
ure episode in Bdnfþ/þ slices incubated for 4 h with MDL or DMSO. Signal intensity at
m the same animal. *p < 0.05; **p < 0.01. Error bars denote SEM.
M. Puskarjov et al. / Neuropharmacology 88 (2015) 103e109 1073.2. Developmental up-regulation of KCC2 takes place in the Bdnf/
hippocampus
Overexpression or exogenous application of BDNF has been re-
ported to result in increased KCC2 mRNA and protein levels, sug-
gesting that BDNF may play a role in the developmental expression
of KCC2 protein (Aguado et al., 2003; Ludwig et al., 2011b). To
investigate thepossibility that the lackof seizure-induced functional
activation of KCC2 may be a consequence of compromised devel-
opmental up-regulation of KCC2 in Bdnf/ mice, we analyzed the
total hippocampalKCC2protein levels betweennaïve (non-injected)
Bdnf/ mice and their wildtype littermates at P5-6 and P13-14.
Differences in the total protein levels of KCC2 between the two ge-
notypeswere observedneither at P5-6 nor at P13-14 (Figs. 3A and B;
P5-6: 89± 7.2% of Bdnfþ/þ; n¼ 12 hippocampi fromboth genotypes;
p ¼ 0.129; Wilcoxon matched pairs test; P13-14: 89.5 ± 12.7% of
Bdnfþ/þ; n ¼ 6 Bdnf/ and 8 Bdnfþ/þ hippocampi; p ¼ 0.312; one-
tailed Student's t-test). Moreover, at P14, when functional up-
regulation of KCC2 reaches its adult levels in wildtype mouse CA1
neurons (Khirug et al., 2005), no difference was observed in DEGABA
between the two genotypes (Fig. 3C; Bdnf/: 9.91 ± 0.78 mV/
50 mm; n ¼ 11 neurons; Bdnfþ/þ: 9.71 ± 1.04 mV/50 mm; n ¼ 6
neurons; p ¼ 0.44; one-tailed Student's t-test).
4. Discussion
We show here that the fast functional up-regulation of KCC2 in
the mouse hippocampus following neonatal status epilepticus is
dependent on BDNF. In our previous experiments, both a kainate-
induced seizure episode in P5-7 rats and seizure-like activity
induced via kainate application to brain slices led to a rapid
enhancement of the efﬁcacy of neuronal Cl extrusion capacity and
to a hyperpolarizing EGABA shift in CA1 pyramidal neurons. This was
accompanied by a large increase in the surface expression of KCC2
(Khirug et al., 2010). Interestingly, a similar effect has been recently
described in P5-7 rat motoneurons in the context of spinal cord
injury (Bos et al., 2013), suggesting that in the neonate thismay be a
general ﬁrst-in-line neuronal response to seizures and trauma (cf.
Kaila et al., 2014b).
After the initial functional up-regulation of KCC2 observed in
the present study, a progressive calpain-dependent down-regu-
lation of KCC2 protein and neuronal Cl extrusion capacity ensued.
This is in accord with the reported down-regulation of KCC2 in the
intact neonatal hippocampal preparation following sustained
kainate-triggered ictal events (Nardou et al., 2011) and the
calpain-dependency of KCC2 down-regulation in CA1 pyramidal
neurons of juvenile rats (Puskarjov et al., 2012). Indeed, a recentFig. 3. Developmental up-regulation of KCC2 protein and function in the mouse hippoca
quantiﬁcation of KCC2 signal (~140 kDa) from P5-6 (A) and P13-14 (B) whole hippocampi o
control. No signiﬁcant differences in KCC2 protein expression was observed between the ge
was observed between P14 Bdnf/ and Bdnfþ/þ mice. Error bars denote SEM.study demonstrated that hippocampal KCC2 is targeted by
calpain-mediated cleavage in a rat model of late gestation
hypoxia-ischemia (Jantzie et al., 2014), and this may well repre-
sent a mechanism that contributes to the brain damage-related
down-regulation of KCC2 in human babies (Robinson et al., 2010).
Our previous work demonstrated that both the increase in
surface expression of KCC2 and the enhanced Cl extrusion ca-
pacity were abolished by the kinase inhibitor K252a. By contrast, in
mature hippocampal neurons this drug has been shown to prevent
TrkB-mediated down-regulation of KCC2 induced by exogenous
BDNF or NT-4 (Rivera et al., 2002) or endogenous BDNF following
NMDA receptor activation (Rivera et al., 2004). In these cells, BDNF-
induced down-regulation of KCC2 appears to require activation of
the TrkB-phospholipase-Cg1 (PLCg1) signaling pathway that is
heavily implicated in the process of epileptogenesis (Kaila et al.,
2014b; Rivera et al., 2004). BDNF has been shown to exert a
developmental stage-dependent effect also on the function of
GABAARs. While at P6 BDNF rapidly potentiates GABAAR-mediated
currents of CA1 pyramidal neurons, by P10 this effect is lost, and
from ~P14 onwards BDNF suppresses GABAAR function (Mizoguchi
et al., 2003). This kind of striking age-dependent co-regulation of
KCC2 and GABAARs is in line with the qualitative change in BDNF-
TrkB signaling that takes place around P12 in the rodent hippo-
campus and cortex (Di Lieto et al., 2012; Knüsel et al., 1994), and
may in part be explained by the apparently age-dependent
response of TrkB phosphorylation at its PLCg1 binding site (Di
Lieto et al., 2012).
Findings of the above kind may also shed light on the mecha-
nisms which underlie the well-known differences between sei-
zures in neonates and adults that have been observed in
neurological and pharmacological work (cf. Haut et al., 2004;
L€oscher et al., 2013; Volpe, 2008). Thus, the present data and
those by Mizoguchi et al. (2003) suggest that, in a manner opposite
to what is observed in adults, seizure-induced release of BDNF in
the early postnatal period enhances the efﬁcacy of inhibition by
increasing the amplitude of the GABAAR-mediated current and by
inducing a negative shift in its reversal potential.
Another key ﬁnding in the present work is that the develop-
mental up-regulation of hippocampal KCC2 protein and transport
functionality takes place in the complete absence of BDNF
expression in vivo. This indicates that although BDNF has been
shown to exert an accelerating effect on neuronal development
including the up-regulation of KCC2 (Aguado et al., 2003; Kaila
et al., 2014a; Ludwig et al., 2011b), it is not a necessary compo-
nent for KCC2 up-regulation to take place during ontogenesis.
Indeed, other trophic factors act in a parallel and apparently
redundant manner with KCC2-regulating transcriptional pathwaysmpus takes place in the absence of BDNF. Representative Western blot analysis and
f non-injected (naïve) Bdnf/ and Bdnfþ/þ littermates. Tubulin was used as a loading
notypes at either age. C, No signiﬁcant difference in DEGABA of CA1 pyramidal neurons
M. Puskarjov et al. / Neuropharmacology 88 (2015) 103e109108downstream of BDNF (Ludwig et al., 2011a). Reduction in BDNF
expression has been previously shown to result in a decrease of
both frequency and amplitude of GABAergic inhibitory post-
synaptic currents in various central neurons (e.g. Abidin et al.,
2008; Laudes et al., 2012). The present observations suggest that
such effects are unlikely to be a consequence of reduced neuronal
Cl extrusion.
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